Insight Molecular Diagnostics Inc.

NasdaqCM:IMDX Stock Report

Market Cap: US$171.8m

Insight Molecular Diagnostics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:IMDX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
27 Apr 26BuyUS$2,032,251Broadwood Capital, Inc.Company570,184US$3.64
20 Apr 26BuyUS$652,876Broadwood Capital, Inc.Company182,861US$3.88
10 Feb 26BuyUS$2,999,999Broadwood Capital, Inc.Company521,739US$5.75

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of IMDX?
Owner TypeNumber of SharesOwnership Percentage
Public Companies2,764,0788.56%
Individual Insiders4,065,93212.6%
Institutions4,215,48113.1%
General Public5,751,40817.8%
Hedge Funds15,491,14048%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 81.41% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
39.3%
Broadwood Capital, Inc.
12,684,884US$67.5m6.31%3.8%
10.1%
Patrick Smith
3,258,485US$17.3m0%no data
8.69%
AWM Investment Company Inc
2,806,256US$14.9m-0.28%1.17%
8.56%
Bio-Rad Laboratories, Inc.
2,764,078US$14.7m0%no data
2.93%
Pura Vida Investments, LLC
947,134US$5.0m0%26.49%
2.6%
Alyeska Investment Group, L.P.
840,777US$4.5m0%0.01%
1.66%
Vanguard Capital Management, LLC
537,161US$2.9m0%no data
1.22%
Heights Capital Management, Inc.
392,545US$2.1m0%0.41%
0.96%
John Gutfreund
310,272US$1.7m0%no data
0.81%
Geode Capital Management, LLC
262,053US$1.4m13.5%no data
0.77%
FNY Investment Advisers, LLC
247,421US$1.3m510%0.61%
0.64%
Andrea James
206,060US$1.1m8.99%no data
0.47%
Andrew Arno
152,162US$809.5k56.6%no data
0.42%
BlackRock, Inc.
135,345US$720.0k3.03%no data
0.41%
Vanguard Fiduciary Trust Company
132,591US$705.4k23.4%no data
0.39%
Family Office Research, LLC
127,266US$677.1k0%0.26%
0.32%
Millennium Management LLC
103,470US$550.5k68.6%no data
0.22%
Ghisallo Capital Management LLC
70,695US$376.1k0%0.01%
0.17%
Susquehanna International Group, LLP
56,093US$298.4k-22.6%no data
0.16%
State Street Global Advisors, Inc.
50,754US$270.0k6.28%no data
0.15%
Northern Trust Global Investments
49,090US$261.2k0.47%no data
0.12%
Andrew Last
39,509US$210.2k776%no data
0.12%
Joshua Riggs
38,365US$204.1k995%no data
0.11%
Louis Silverman
36,564US$194.5k2,240%no data
0.11%
Morgan Stanley
36,088US$192.0k0.49%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/18 21:36
End of Day Share Price 2026/06/18 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Insight Molecular Diagnostics Inc. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Paul KnightBrean Capital Historical (Janney Montgomery)
Mark MassaroBTIG
null nullKeyBanc Capital Markets Inc.